HIV
From the Journals
Focus groups seek transgender experience with HIV prevention
From the Journals
Nearly half of STI events go without HIV testing
Missed opportunities for HIV diagnosis have the potential to delay linkage to antiretroviral therapy or PrEP and prevention services.
Conference Coverage
A point-of-care urine test is on the way for PrEP adherence
Nearly perfect accuracy, sensitivity seen.
Conference Coverage
More postpartum weight gain with dolutegravir-based ART
Though the association was clear, clinical implications aren’t known.
Conference Coverage
HIV free 30 months after stem cell transplant, is the London patient cured?
Conference Coverage
Testosterone therapy linked to CV risk in men with HIV
Conference Coverage
Descovy safety no match for cost savings with generic Truvada, study says
Analysis indicates the cost differential is worth only $370 more than the likely generic price.
From the Journals
Monthly injection therapy for HIV found noninferior to daily oral dosing
Injections of long-acting suspensions of cabotegravir and rilpivirine show promise for the control of HIV.
Latest News
HCV a risk in HIV-negative MSM who use PrEP
HIV-negative MSM on PrEP are at risk for HCV-infection, with risk-factors similar to those in HIV-positive MSM.
Opinion
Provide appropriate sexual, reproductive health care for transgender patients
To obtain an appropriate sexual history from transgender patients, focus on organs and activities instead of gender.
News
CDC finds that efforts to reduce new HIV infections have stalled
The agency has proposed a federal initiative to improve diagnosis, treatment, and prevention in areas of greatest need throughout the country.